Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced a private placement of 2,500 common shares at ¥40,000 per share for gross proceeds of ¥100,000,000 on March 24, 2016. The transaction will include participation from a returning investor, Trans Genic Inc. and a new investor, Immuno-Biological Laboratories Co., Ltd for 1,250 shares each. As part of the transaction, Trans Genic Inc. will acquire 3.9% stake in the company, increasing its stake from 31.7% to 35.6% and Immuno-Biological Laboratories Co., Ltd. will acquire 11.9% stake in the company.

The transaction will take place through third party capital increase. The transaction was approved by the board of directors of Trans Genic Inc. The share acquisition date is March 31, 2016.